The healthcare industry is ripe for disruptions.
*Stock prices used were the afternoon prices of Sept. 14, 2026. The video was published on Sept. 16, 2026.
Should you buy stock in Hims & Hers Health right now?
Before you buy stock in Hims & Hers Health, it’s worth evaluating the company’s fundamentals, growth trajectory, and current valuation against the broader healthcare landscape.
The Motley Fool’s Stock Advisor service has delivered an average return of 938% — significantly outperforming the S&P 500’s 211% over the same period.*
*Stock Advisor returns as of September 16, 2026.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy.
Also Read
- Quantum Computing Emerges as a New Investment Focus Amid AI Development Slowdown; Four Stocks to Watch
- New Study Reveals Significant Association Between ADHD and Gastrointestinal Disorders
- The $1 Million Pennsylvania Derby: A Pivotal Breeders’ Cup Prep Race
- Trump Champions Law and Order Messaging to Aid North Carolina Senate Race


